BRD2 and neoplasm: To investigate differences between immune compartments within the NAT relative to the TME, we performed magnetic-bead based CD45+ cell enrichment of patient-matched NAT and tumor samples and subjected the samples to gene expression analysis using the NanoString Platform (Fig. 4A–4H, supplemental Table S2).